Though previous studies suggested both IL-37 and IL-18 as estimators of disease activity in patients with AOSD, controversies exist as to whether IL-18 could serve as a marker for disease remission and follow-up [1]. The gene discussed is IL18; the disease is adult-onset Still disease.